Cargando…
Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone
Pure red cell aplasia (PRCA) associated with erythropoiesis-stimulating agents (ESAs), which were first reported in 1998, usually occurs with subcutaneous administration of epoetin alfa (Eprex(Ⓡ)). Improvements in ESA storage, handling, and administration methods have reduced the PRCA incidence. Con...
Autores principales: | Okahashi, Nozomi, Kubo, Masayuki, Hoshino, Ei, Uchihara, Masahito, Amano, Itsuto, Tanaka, Haruyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381349/ https://www.ncbi.nlm.nih.gov/pubmed/34980800 http://dx.doi.org/10.2169/internalmedicine.8823-21 |
Ejemplares similares
-
Erythropoietin‐induced pure red cell aplasia
por: Yeung, Vivian K. P.
Publicado: (2022) -
Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021) -
Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
por: Rahbar, Maryam, et al.
Publicado: (2017) -
Ten year follow up of erythropoietin induced autoimmune pure red cell aplasia
por: Ram, R., et al.
Publicado: (2013) -
Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy
por: Padhi, Somanath, et al.
Publicado: (2020)